Kebilidi is the first approved gene therapy that can be directly administered to the brain. Its OK secures a priority review ...
PTC Therapeutics' Kebilidi gains FDA accelerated approval as the first brain-administered gene therapy in the U.S. for AADC ...
Barclays raised the firm’s price target on PTC Therapeutics (PTCT) to $45 from $43 and keeps an Equal Weight rating on the shares. After ...
Sami Corwin has given his Buy rating due to a combination of factors that favor PTC Therapeutics’ market position. The recent FDA approval of Kebilidi, a groundbreaking gene therapy for AADC ...
The FDA issued its first stamp of approval for a cell or gene therapy back in 2017 to Novartis' Kymriah. | The gene therapy ...
The National Hurricane Center reports that Potential Tropical Cyclone 19 has developed into Tropical Depression 19 in the ...
The FDA has followed in the footsteps of its European counterparts and granted accelerated approval to PTC Therapeutics’ gene ...
On Wednesday, PTC 19, formerly known as Invest 99L, was over 400 miles east of Isla Guanaja, Honduras, and 290 miles ...
22hon MSN
PTC Industries stock surged 278% in two years, boosted by strong financials and significant orders, including one from Israel ...
The FDA has cleared PTC Therapeutics’ gene therapy for AADC deficiency, an ultra-rare disease that impacts the ...
Potential Tropical Cyclone Nineteen (PTC 19) has formed in the western Caribbean. This system will likely to develop into the ...
LONDON, Nov 14 (Reuters) - There are certain phrases that Wachuka Gichohi finds difficult to hear after enduring four years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback